Griffin Asset Management, Inc. Vivos Therapeutics, Inc. Transaction History

Griffin Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$1.12 - $2.18 $78,624 - $153,036	-70,200 Closed	0 $0
Q1 2022 Apr 12, 2022	BUY	$1.63 - $3.63 $44,336 - $98,736	27,200 Added 63.26%	70,200 $188,000
Q4 2021 Jan 28, 2022	SELL	$2.25 - $4.11 $14,625 - $26,715	-6,500 Reduced 13.13%	43,000 $97,000
Q2 2021 Jul 28, 2021	SELL	$4.83 - $9.67 $49,266 - $98,634	-10,200 Reduced 17.09%	49,500 $245,000
Q1 2021 May 04, 2021	BUY	$6.01 - $8.9 $358,797 - $531,330	59,700 New	59,700 $396,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Griffin Asset Management, Inc. with notifications on news.